Variant report
Variant | esv32904 |
---|---|
Chromosome Location | chr13:55305891-55308489 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:55286253..55286882-chr13:55307575..55308197,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536865090 | chr13:55306456-55306457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550758488 | chr13:55306477-55306478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2898211 | chr13:55306494-55306495 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs112531090 | chr13:55306500-55306501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74698235 | chr13:55306549-55306550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115119163 | chr13:55306550-55306551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187494515 | chr13:55306564-55306565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141588487 | chr13:55306576-55306577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538927448 | chr13:55306582-55306583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558627689 | chr13:55306585-55306586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577946627 | chr13:55306599-55306600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533972414 | chr13:55306613-55306614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1471449 | chr13:55306699-55306700 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs574022881 | chr13:55306709-55306710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559023450 | chr13:55306715-55306716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12859404 | chr13:55306725-55306726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12862712 | chr13:55306734-55306735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528164353 | chr13:55306744-55306745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12859472 | chr13:55306773-55306774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12859807 | chr13:55306802-55306803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377650951 | chr13:55306812-55306813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192692707 | chr13:55306816-55306817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556295559 | chr13:55306817-55306818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576268231 | chr13:55306881-55306882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545291686 | chr13:55306900-55306901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565475324 | chr13:55306973-55306974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73497160 | chr13:55306995-55306996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572339809 | chr13:55307011-55307012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147035733 | chr13:55307021-55307022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560945127 | chr13:55307038-55307039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs202107096 | chr13:55307079-55307080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11331122 | chr13:55307080-55307081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs398037601 | chr13:55307081-55307082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183384564 | chr13:55307086-55307087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs11838910 | chr13:55307105-55307106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569864446 | chr13:55307146-55307147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532377291 | chr13:55307169-55307170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142014127 | chr13:55307209-55307210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188616164 | chr13:55307240-55307241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7988018 | chr13:55307266-55307267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs553834393 | chr13:55307275-55307276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567329025 | chr13:55307277-55307278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536334496 | chr13:55307297-55307298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574834255 | chr13:55307467-55307468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs34066033 | chr13:55307620-55307621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543631911 | chr13:55307683-55307684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1871248 | chr13:55307711-55307712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113872921 | chr13:55307735-55307736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200764149 | chr13:55307766-55307767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1471448 | chr13:55307790-55307791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:55306400-55309000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr13:55306600-55308000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr13:55306800-55307400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr13:55306800-55308000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr13:55307000-55307600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr13:55307200-55307800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr13:55307600-55308000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr13:55307600-55308200 | Enhancers | HUES64 Cell Line | embryonic stem cell |